Form 4 for ORMP ORAMED PHARMACEUTICALS INC.
Accepted 2026-01-29 00:00:00 ET · period of report 2026-01-22 · accession 0001213900-26-009477 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-29 | 2026-01-22 | ORMP | Hexter Joshua | COO, CBO | M - OptEx | $0.00 | +19.0K | 1.06M | +2% | $0 |
| D | 2026-01-29 | 2026-01-22 | ORMP | Hexter Joshua | COO, CBO | M - OptEx | $0.00 | -19.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-22 | M | A | 19,000 | $0.00 | 1,064,495 | D | — | — | (F1) Represents the vesting of performance stock units ("PSUs") granted to the Reporting Person on December 31, 2025, which vested on January 22, 2026, upon the Issuer's common stock, par value $0.012 per share ("Common Stock"), achieving a specified price per share. The shares of Common Stock were received for no consideration upon such vesting. |
| 2 | Derivative | Performance Stock Units | 2026-01-22 | M | D | 19,000 | $0.00 | 0 | D | — · — to — | 19,000 Common Stock | (F1) Represents the vesting of performance stock units ("PSUs") granted to the Reporting Person on December 31, 2025, which vested on January 22, 2026, upon the Issuer's common stock, par value $0.012 per share ("Common Stock"), achieving a specified price per share. The shares of Common Stock were received for no consideration upon such vesting. (F2) Each PSU represented a contingent right to receive one share of the Issuer's Common Stock upon achievement of the applicable performance criteria. |